Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Terpesomes as Advanced Nanocarriers for Enhanced Drug Delivery: Formulation Strategies, Mechanistic Insights, and Therapeutic Applications.

Created on 16 Oct 2026

Authors

Anroop B Nair, Mohamed A Morsy, Ahmed M Agiba, Rofida Albash

Published in

AAPS PharmSciTech. Volume 27. Issue 7. Sep 21, 2026. Epub Sep 21, 2026.

Abstract

Terpenes have a low potential for irritation and are classified as Generally Recognized as Safe (GRAS) chemicals. Terpenes possess favorable biological properties that support their use in drug delivery. Some terpenes and essential oils have been encapsulated in nanostructured systems called terpesomes to overcome their chemical instability. Compared to conventional vesicles, terpesomes are new vesicular structures that showed greater membrane penetration. The capacity of terpesomes to increase permeability across membranes while decreasing systemic absorption is one of their main benefits. Terpesomes enhance drug permeation by improving membrane interaction and increasing drug transport across biological barriers. The structure, characterization, penetration processes, and applications of terpesomes are all addressed in this review. Overall, this review highlights that the enhanced penetration capability of terpesomes makes them promising lipid vesicular carriers for a wide range of pharmaceutical applications.

PMID:
42768238
Bibliographic data and abstract were imported from PubMed on 16 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 33
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement